Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:42 PM
Ignite Modification Date:
2025-12-24 @ 6:42 PM
NCT ID:
NCT03437057
Eligibility Criteria:
Inclusion Criteria
* Over 18 yo patients
* Patients with 1 renal lithiasis (at least) requiring treatment with extracorporeal lithotripsy
* Patients taking Kardégic 75 (monotherapy
Exclusion Criteria:
* Patients with known (or previously known) bleeding disorders on the pre-treatment assessment
* Patients with anticoagulant therapy or other anti-aggregating therapy (eg Kardegic at 75mg, AVK, NACO, LMWH, HNF, P2Y12 inhibitor)
* Patients with another contrindication to the ECL.
* Patients with prescription of more than the outset 1 ECL session
* Tutelage, curatorship, justice safeguarding, deprived of liberties, unaffiliated SS, impaired comprehension abilities, pregnant and lactating women.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03437057
Study Brief:
Protocol Section:
NCT03437057